These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20336303)

  • 21. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
    Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M
    Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy.
    Staudt A; Herda LR; Trimpert C; Lubenow L; Landsberger M; Dörr M; Hummel A; Eckerle LG; Beug D; Müller C; Hoffmann W; Weitmann K; Klingel K; Kandolf R; Kroemer HK; Greinacher A; Felix SB
    Clin Pharmacol Ther; 2010 Apr; 87(4):452-8. PubMed ID: 20054293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
    Mobini R; Maschke H; Waagstein F
    Autoimmun Rev; 2004 Jun; 3(4):277-84. PubMed ID: 15246023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
    Warraich RS; Dunn MJ; Yacoub MH
    Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C; Wittchen F; Suckau L; Witt H; Noutsias M; Fechner H; Schultheiss HP; Poller W
    Eur Heart J; 2008 May; 29(9):1168-80. PubMed ID: 18390538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship.
    Warraich RS; Griffiths E; Falconar A; Pabbathi V; Bell C; Angelini G; Suleiman MS; Yacoub MH
    FASEB J; 2006 Apr; 20(6):651-60. PubMed ID: 16581973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
    Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy.
    Okazaki T; Honjo T
    Trends Mol Med; 2005 Jul; 11(7):322-6. PubMed ID: 15935731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
    Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.
    Christ T; Wettwer E; Dobrev D; Adolph E; Knaut M; Wallukat G; Ravens U
    J Mol Cell Cardiol; 2001 Aug; 33(8):1515-25. PubMed ID: 11448139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.
    Okazaki T; Tanaka Y; Nishio R; Mitsuiye T; Mizoguchi A; Wang J; Ishida M; Hiai H; Matsumori A; Minato N; Honjo T
    Nat Med; 2003 Dec; 9(12):1477-83. PubMed ID: 14595408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.
    Baba A
    Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
    Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
    Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.